Rojas-Vázquez, Sara https://orcid.org/0000-0001-6104-7062
Lozano-Torres, Beatriz
García-Fernández, Alba
Galiana, Irene
Perez-Villalba, Ana https://orcid.org/0000-0002-5330-2374
Martí-Rodrigo, Pablo https://orcid.org/0000-0002-1049-0918
Palop, M. José
Domínguez, Marcia
Orzáez, Mar https://orcid.org/0000-0003-3231-5835
Sancenón, Félix
Blandez, Juan F.
Fariñas, Isabel https://orcid.org/0000-0003-2903-4960
Martínez-Máñez, Ramón https://orcid.org/0000-0001-5873-9674
Article History
Received: 10 August 2023
Accepted: 10 January 2024
First Online: 26 January 2024
Competing interests
: B. L.-T., A. G.-F., I. G., M. O., R. M.-M., F. S, and J. F. B. have filed a patent application related to this research with the “Oficina Española de Patentes y Marcas”. R.M.-M. is co-founder of Senolytic Therapeutics, Inc. (USA) and Senolytic Therapeutics, S.L. (Spain). The remaining authors declare no competing interests.